Stocktoria
Edesa Biotech, Inc. EDSA
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2008-08-25
Edesa Biotech, Inc. financials (annual)
Bars are annual figures from 2015 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | $0 | $328,801 | $211,849 | $228,287 | $1.3M | $758,689 |
| R&D expense | $3.7M | $2.9M | $4.8M | $13.3M | $17.9M | $3.3M | $2.1M | $2.0M | $1.7M | $1.0M |
| Operating income | -$7.9M | -$7.0M | -$9.2M | -$18.4M | -$23.7M | -$6.4M | -$5.1M | -$5.2M | -$4.9M | -$4.3M |
| Income tax | $800 | $800 | $800 | $800 | $800 | $800 | $800 | $800 | $7,200 | $36,800 |
| Net income | -$7.2M | -$6.2M | -$8.4M | -$17.5M | -$13.3M | -$6.4M | -$5.0M | -$5.0M | -$5.0M | -$2.8M |
| EPS (diluted) | — | — | — | — | — | — | — | — | $-0.57 | $-0.36 |
| Operating cash flow | -$7.3M | -$4.9M | -$6.6M | -$12.3M | -$13.7M | -$5.0M | -$4.6M | -$4.7M | -$4.5M | -$4.4M |
| Free cash flow | — | — | -$6.6M | -$12.3M | -$13.7M | -$5.0M | -$5.0M | -$5.0M | -$4.9M | -$4.7M |
| Cash & equivalents | $10.8M | $1.0M | $5.4M | $7.1M | $7.8M | $7.2M | $3.7M | $4.6M | $7.4M | $4.0M |
| Inventory | — | — | — | — | — | — | $224,267 | $68,114 | $249,430 | $557,280 |
| Total assets | $13.5M | $3.8M | $8.9M | $11.6M | $14.6M | $10.8M | $11.8M | $7.7M | $12.9M | $10.4M |
| Total liabilities | — | $1.8M | $1.8M | $2.2M | $1.5M | $1.7M | — | — | — | $2.4M |
| Shareholders' equity | $12.5M | $2.0M | $7.0M | $9.4M | $13.1M | $6.6M | $3.6M | $7.4M | $12.3M | $8.0M |
Growth · year-over-year
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | — | — | — | — | -100.0% | +55.2% | -7.2% | -82.0% | +67.6% | +103.9% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-09-30. Facts plus Stocktoria's own computed scores — not investment advice.